236 related articles for article (PubMed ID: 34070159)
21. Tuning T Cell Activation: The Function of CD6 At the Immunological Synapse and in T Cell Responses.
Santos RF; Oliveira L; Carmo AM
Curr Drug Targets; 2016; 17(6):630-9. PubMed ID: 26028048
[TBL] [Abstract][Full Text] [Related]
22. Identification of a mouse protein homologous to the human CD6 T cell surface protein and sequence of the corresponding cDNA.
Robinson WH; Prohaska SS; Santoro JC; Robinson HL; Parnes JR
J Immunol; 1995 Nov; 155(10):4739-48. PubMed ID: 7594475
[TBL] [Abstract][Full Text] [Related]
23. Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients.
Cenit MC; Martínez-Florensa M; Consuegra M; Bonet L; Carnero-Montoro E; Armiger N; Caballero-Baños M; Arias MT; Benitez D; Ortego-Centeno N; de Ramón E; Sabio JM; García-Hernández FJ; Tolosa C; Suárez A; González-Gay MA; Bosch E; Martín J; Lozano F
PLoS One; 2014; 9(11):e113090. PubMed ID: 25402503
[TBL] [Abstract][Full Text] [Related]
24. CD5: a safeguard against autoimmunity and a shield for cancer cells.
Dalloul A
Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the third extracellular domain of CD5 reveals the fold of a group B scavenger cysteine-rich receptor domain.
Rodamilans B; Muñoz IG; Bragado-Nilsson E; Sarrias MR; Padilla O; Blanco FJ; Lozano F; Montoya G
J Biol Chem; 2007 Apr; 282(17):12669-77. PubMed ID: 17322294
[TBL] [Abstract][Full Text] [Related]
26. Extracellular isoforms of CD6 generated by alternative splicing regulate targeting of CD6 to the immunological synapse.
Castro MA; Oliveira MI; Nunes RJ; Fabre S; Barbosa R; Peixoto A; Brown MH; Parnes JR; Bismuth G; Moreira A; Rocha B; Carmo AM
J Immunol; 2007 Apr; 178(7):4351-61. PubMed ID: 17371992
[TBL] [Abstract][Full Text] [Related]
27. Structure and chromosomal location of the human CD6 gene: detection of five human CD6 isoforms.
Bowen MA; Whitney GS; Neubauer M; Starling GC; Palmer D; Zhang J; Nowak NJ; Shows TB; Aruffo A
J Immunol; 1997 Feb; 158(3):1149-56. PubMed ID: 9013954
[TBL] [Abstract][Full Text] [Related]
28. Relevance of CD6-mediated interactions in T cell activation and proliferation.
Gimferrer I; Calvo M; Mittelbrunn M; Farnós M; Sarrias MR; Enrich C; Vives J; Sánchez-Madrid F; Lozano F
J Immunol; 2004 Aug; 173(4):2262-70. PubMed ID: 15294938
[TBL] [Abstract][Full Text] [Related]
29. The lymphocyte glycoprotein CD6 contains a repeated domain structure characteristic of a new family of cell surface and secreted proteins.
Aruffo A; Melnick MB; Linsley PS; Seed B
J Exp Med; 1991 Oct; 174(4):949-52. PubMed ID: 1919444
[TBL] [Abstract][Full Text] [Related]
30. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
31. The immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.
Soldevila G; Raman C; Lozano F
Curr Opin Immunol; 2011 Jun; 23(3):310-8. PubMed ID: 21482089
[TBL] [Abstract][Full Text] [Related]
32. The membrane-proximal scavenger receptor cysteine-rich domain of CD6 contains the activated leukocyte cell adhesion molecule binding site.
Whitney GS; Starling GC; Bowen MA; Modrell B; Siadak AW; Aruffo A
J Biol Chem; 1995 Aug; 270(31):18187-90. PubMed ID: 7543097
[TBL] [Abstract][Full Text] [Related]
33. Interaction of recombinant and natural soluble CD5 forms with an alternative cell surface ligand.
Calvo J; Places L; Padilla O; Vilà JM; Vives J; Bowen MA; Lozano F
Eur J Immunol; 1999 Jul; 29(7):2119-29. PubMed ID: 10427974
[TBL] [Abstract][Full Text] [Related]
34. The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation.
Kofler DM; Severson CA; Mousissian N; De Jager PL; Hafler DA
J Immunol; 2011 Sep; 187(6):3286-91. PubMed ID: 21849685
[TBL] [Abstract][Full Text] [Related]
35. CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn.
Burgess KE; Yamamoto M; Prasad KV; Rudd CE
Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9311-5. PubMed ID: 1384049
[TBL] [Abstract][Full Text] [Related]
36. Expression of the CD6 T lymphocyte differentiation antigen in normal human brain.
Mayer B; Funke I; Seed B; Riethmüller G; Weiss E
J Neuroimmunol; 1990; 29(1-3):193-202. PubMed ID: 2211985
[TBL] [Abstract][Full Text] [Related]
37. Targeting CD6 for the treatment of experimental autoimmune uveitis.
Zhang L; Li Y; Qiu W; Bell BA; Dvorina N; Baldwin WM; Singer N; Kern T; Caspi RR; Fox DA; Lin F
J Autoimmun; 2018 Jun; 90():84-93. PubMed ID: 29472120
[TBL] [Abstract][Full Text] [Related]
38. CD6 as a therapeutic target in autoimmune diseases: successes and challenges.
Pinto M; Carmo AM
BioDrugs; 2013 Jun; 27(3):191-202. PubMed ID: 23568178
[TBL] [Abstract][Full Text] [Related]
39. Evolutionary and functional evidence for positive selection at the human CD5 immune receptor gene.
Carnero-Montoro E; Bonet L; Engelken J; Bielig T; Martínez-Florensa M; Lozano F; Bosch E
Mol Biol Evol; 2012 Feb; 29(2):811-23. PubMed ID: 21998275
[TBL] [Abstract][Full Text] [Related]
40. CD6 binds to pathogen-associated molecular patterns and protects from LPS-induced septic shock.
Sarrias MR; Farnós M; Mota R; Sánchez-Barbero F; Ibáñez A; Gimferrer I; Vera J; Fenutría R; Casals C; Yélamos J; Lozano F
Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11724-9. PubMed ID: 17601777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
